I think you’re mistaking my point. I own a lot of shares and have been in this company for 16 years. If I can help them for a couple of months and get more shares it’s a mutual deal. But they’re not selling 10 million preferred C shares to retail, they exist for a much deeper reason.
My personal feeling is that they’re either for a joint venture with a BP (my speculation is Roche or Merck) or for a buy in from a big fund such as Google Ventures. Maybe a combo of BP and Fund. Maybe they put out the shares as a way to attract either of the two, maybe because they already have a deal worked out.
Beyond that I believe the combination of one after another filings; the MAA, manufacturing certification, Journal Article, a lawsuit against MMs/AF/Stat, SEC lawsuit against MMs/AF/Stat, and then MHRA marketing approval, etc. will unleash a huge squeeze and I believe that’s why we’re seeing so much short squawking lately as they try to cover at the lowest prices possible for as long as possible. They may be vultures but they’re not stupid. They’ve had 62 trading days since May 10th to recover 10s of millions of shares they dumped into the market that day. They think they’ve outsmarted NWBO but they’ve severely underestimated them. I spoke to Cofer Black in Chicago; that dude’s scary.
I don’t know precisely what they have up their sleeve but I think it’s going to be an interesting surprise to a lot of people.
